The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial

The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial

Bibliographic Details
Main Authors: Masurekar, A, Fong, C, Hussein, A, Revesz, T, Hoogerbrugge, P M, Love, S, Ciria, C, Parker, C, Krishnan, S, Saha, V
Format: Online
Language:English
Published: Nature Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003420/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003420/

Similar Items